SECUKINUMAB 150 mg in 1mL Injection, SECUKINUMAB 300 mg in 2mL Solution for Injection

Deadline

Not available — this notice may describe a possible future opportunity.

Region

Not specified

Value

£4,638,166

Type

Award,contract

SME fit

—

Duration

—

Description

Supply of SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300mg in 2mL Injections to meet clinical need in the Western Trust until 30/11/2028.

Quick actions

View original notice

Key details

Reference